Role of Serum ADAM 17 (A Disintegrin And Metalloprotease 17) and Caspase 3 in Patients With Chronic Kidney Disease
Clinical trial NCT06392425 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06392425
- Sponsor
- Assiut University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-26
- Primary completion
- 2027-03-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.